Training and Education

Zotefoams hosts virtual opening of new £23million plant in Poland

Over 140 customers from 21 countries today attended the virtual opening of Zotefoams’ new state-of-the-art plant located in Brzeg in south-west Poland. In a key strategic move to increase global capacity and optimise service levels for many customers in...

How can you prevent weak maths skills hindering student performance?

An increasing number of students are struggling to keep up with the maths content in the crucial first months of their degree, despite the measures lecturers are taking to continually adapt their teaching to try and meet the increasingly...

LAUDA to expand its portfolio with new LAUDA Versafreeze product line

LAUDA – Experts In Thermal Control And Measurement Providing Innovative Solutions For Thermal Process Control, Chilled Water Applications, Water Baths, Freezers, Incubators, Shakers, Stills, Tensiometers, Viscometers And Contact Angle Measurement. LAUDA, the world market leader in temperature control equipment and...

BioScience Today Launches Digital Packages to Support Companies During the COVID-19 Pandemic

As the Bio-Life science industry continues to be impacted by the COVID-19 pandemic, it is has become even more vital for companies to sustain their presence during these challenging times. Since the COVID-19 pandemic began in March 2020, BioScience...

Zotefoams’ ZOTEK® F foam chosen by InsulFab for safe and effective delivery of COVID-19 vaccine

High-performance closed cell, crosslinked fluoropolymer foam helps ensure safe and secure transportation of ultra-cold chain vaccine As part of the USA’s Operation Warp Speed (OWS) initiative to combat the COVID-19 pandemic, Texas, USA-based InsulFab has harnessed the unique properties...

Data science beginning to drive healthcare

Teesside University’s £22m National Horizons Centre opened in September 2019 with two objectives, to drive research into bioprocessing, digital and health, and to plug the yawning skills gap. Research, teaching and enterprise are its watchwords. The work of the National...

Prof. James Leiper, Associate Medical Director at the British Heart Foundation, looks at the future of heart and circulatory disease research

“There’s a lot of very exciting cardiovascular research going on at the moment which the BHF is heavily investing in – from stem cell therapy and regenerative medicine to identifying genes that could be linked to heart and circulatory...

HEART DISEASE RESEARCHERS SET TO WORK WITH THE NOBEL PRIZE-WINNING GENETIC SCISSORS

By Dr Leanne Grech, Research Engagement Officer at the British Heart Foundation We can all agree that 2020 has been a difficult year, but a silver lining was two women winning the Nobel Prize in Chemistry for developing the tools to...

INDUSTRY-ACADEMIA PARTNERSHIP LAUNCHES ONE STEP MANUFACTURING PROCESS FOR PHARMACEUTICAL DOSAGE FORMS

Cubi-Tech Extrusion Limited, a Cubic Pharmaceuticals Ltd company, puts an end to some of the problems inherent in pharmaceuticals production. Process efficiency and continuous manufacturing are certainly hot topics in the pharmaceutical industry right now, and with good reason. Global population...

WEAPONISING THE FIGHT AGAINST ANTIBIOTIC RESISTANCE

Could faecal transplants be an effective weapon in the fight back against antibiotic resistance? A research team at Guy’s and St Thomas’ NHS Foundation Trust intends to find out, once and for all. By HELEN COMPSON While faecal transplants have been...

HOPE ON THE HORIZON FOR ALZHEIMER’S TREATMENT

Dr Susan Kohlhaas Director of Research at Alzheimer’s Research UK People with dementia have been disproportionately affected by the COVID-19 pandemic. In fact, according to the ONS, a quarter of people who have died from COVID-19 also had dementia. Changes to the...

THE NETPARK NETWORK THAT LOOKS TO THE FUTURE

The North-East Technology Park - or NETPark as it is known - in County Durham provides science, technology and engineering companies with the type of world-class laboratory, clean room and office space they require on the journey from start-up to, frequently,...

EXPERT EQUIPS ENTREPRENEURS TO SURVIVE ADVERSITY

Expert in the field of biological sample storage and logistics management, CRYONISS is also adept at evaluating business continuity plans and identifying the holes that might well prove to be their pitfall. Cheshire-based Cryoniss offers a comprehensive storage service at...

Thriving commercial ecosystems will help universities to keep making an impact beyond Covid-19

Throughout 2020, the life sciences sector has been in the limelight. In the effort to overcome COVID-19, the sector has put into action an unprecedented global application of expertise. The deployment of great minds, public and private investment and...

PROFESSOR HONOURED FOR HER WORK ON PANDEMIC CONTROL

A Women in Science event held earlier this year demonstrated that women are certainly coming into their own in the fields of science, technology, engineering and maths. In this, the final feature in a three-part series about women making waves,...

Creating a Corona Vaccine

Varuni Paranavitane, IP Solicitor,  AA Thornton. As the world faces unprecedented challenges caused by the SARS-Cov-2 virus, we look at the science behind vaccine technology being investigated and how intellectual property rights may play a part in its protection. What is a...

Joe Govier of Connect 2 Cleanrooms Ranked Among UK’s Top 50 Most Ambitious Business Leaders

Joe Govier, CEO and Founder of Connect 2 Cleanrooms, has been named as one of LDC’s Top 50 Most Ambitious Business Leaders for 2020. Now in its third year, the programme, which is supported by The Telegraph, celebrates the inspiring...

Don’t underestimate the logistics challenge as Pfizer vaccine rolls out across the UK

The logistics operation in the UK will be bigger than the largest ever global humanitarian effort Demand for delivery of ultra-low freezers will grow 5-7 fold in the UK High potential for costly stockpiling of vaccines...

£45M to advance gene therapy treatment of chronic kidney diseases

The University of Bristol has secured a £45million deal to advance its ground-breaking gene therapy technology for chronic kidney diseases. The commitment, made by healthcare company Syncona Ltd to Bristol spin-out Purespring Therapeutics, aims to address a global unmet need...

Alternative to invasive prostate cancer biopsies on the horizon

Pioneering research conducted by University of Virginia in collaboration with Manchester UK based APIS Assay Technologies Ltd has discovered Hormone-Upregulated lncRNA within the lymphocyte-specific protein tyrosine kinase (HULLK) is detectable in non-invasive prostate cancer patient samples. The breakthrough data provides a potential new...

UK’s unique national pancreas tissue bank opens for business

The UK’s national tissue bank for pancreatic diseases is open for applications from any UK-based researchers needing samples of blood, urine and saliva to aid their research. The Pancreatic Cancer Research Fund Tissue Bank (PCRF Tissue Bank) was set up...

Biofriendly protocells pump up blood vessels

An international team comprising researchers from the University of Bristol, and Hunan and Central South Universities in China, have prepared biocompatible protocells that generate nitric oxide gas – a known reagent for blood vessel dilation - that when placed...

University of Exeter and Medicines Discovery Catapult combine

The University of Exeter and Medicines Discovery Catapult (MDC) have announced their strategic partnership to accelerate medicines Research & Development (R&D), creating value for the sector and enhancing translational skills. MDC is the national centre for technology, innovation and adoption...

Company Launches to Develop New Innovative Technologies and Products

Headquartered in West Lothian, Scotland, Bluestream Research & Development specialise in health sciences, engineering and technology sector projects and innovations. Founded by Kenneth Redmond, Bluestream Research & Development was launched to offer innovation project support and the company is keen...

Roylance Pharma and Biocair partner to provide end-to-end outsourced storage solution for the life sciences.

Roylance Pharma, a licensed outsourced controlled storage company dedicated to the life sciences, has partnered with Biocair to provide an end to end fully integrated outsourced storage solution for temperature-controlled pharmaceutical and biological materials. Biocair is a global specialist in...

Nemera to acquire Copernicus to boost parenteral product portfolio and small series capabilities

This acquisition strengthens Nemera’s proprietary product offering and establishes operations footprint in Eastern Europe. Nemera today announced that they have entered into an agreement to acquire Copernicus. Copernicus, based in Szczecin Poland, specializes in the development and manufacturing of injection...

Safe’n’Spray: Winner at CPhI Festival of Pharma

Nemera’s  concept device Safe'n'SprayTM was rewarded under the category 'Excellence in Pharma - Drug Delivery Devices'. This recognition was announced during the awards ceremony on 13 October 2020 on the digital platform of CPhI Festival of Pharma. Safe’n’Spray is an integrated device with reusable...

Odin Vision receives NIHR funding to accelerate its AI technology for patient benefit

NIHR (National Institute for Health Research) has recognised Odin Vision as one of the companies to benefit from its new funding stream which accelerates the testing of cutting-edge AI technologies in the NHS. The AI tools and products are the...

UCLB spinout Freeline Closes $120 Million Series C Financing Round

Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, today announced the closing of a $120 million extended Series C financing. The financing augments Syncona’s previously announced Series C investment in Freeline of $40 million (£30.6 million) with an additional $80 million (£61.2 million) of...

New director takes the helm

Teesside University’s £22m National Horizons Centre opened last September with two objectives, to drive research into bioprocessing and to plug the yawning skills gap. Co-author of the UK’s National Industrial Biotechnology Strategy to 2030, Dr Jen Vanderhoven, left, took the...